Management of Patients With Heart Disease for Noncardiac Surgery
- John H. Tinker, MD;
- Carl R. Noback, MD;
- Ronald E. Vlietstra, MD;
- Robert L. Frye, MD
Since this article does not have an abstract, we have provided the first 150 words of the full text.
Excerpt
PHYSICIANS are frequently consulted about the advisability and perioperative management of noncardiac surgery in patients with heart disease. The risks in patients with coronary artery disease have been extensively studied, whereas other types of heart disease, perhaps because of their more uniformly progressive nature, have not proved as amenable to specific risk analysis. Clinical judgment remains central to the assessment of the risk-benefit ratio of any proposed procedure. We intend to present briefly considerations of risk, preoperative pharmacologic management, and a discussion of basic principles of operative and postoperative care.
Prior Myocardial Infarction.— Several retrospective studies have shown that patients with a prior myocardial infarction (MI) have about a 6% incidence of new infarction occurring within seven days of anesthesia and surgery, unless the prior MI was recent.1-3 Operations performed within three months of an MI are associated with
Footnotes
-
This article is one of a series sponsored by the American Heart Association.
-
Reprint requests to Department of Anesthesiology, Mayo Clinic and Medical School, Rochester, MN 55455 (Dr Tinker).
